Pharmacovigilance, at its core, is the science of collecting, monitoring, and assessing information about the safety of medicinal products. Its primary goal is to identify and evaluate adverse events and potential risks associated with these products, such as drugs and vaccines. This process is critical in clinical research because it helps in preventing harm to patients and allows for informed decisions regarding the use of these products.
Phases of Pharmacovigilance:
Data Collection and Reporting: In clinical research, the first step in pharmacovigilance is collecting data on adverse events and other safety-related information. Healthcare professionals, patients, and even pharmaceutical companies play a vital role in reporting these events to regulatory authorities.
Signal Detection: This phase involves identifying patterns or signals in the reported data that may suggest a safety concern. Modern tools and databases aid in the early detection of potential issues.
Risk Assessment: Once a potential safety concern is identified, thorough risk assessment is carried out. This involves evaluating the severity of the risk, the likelihood of occurrence, and the overall impact on patient safety.
Risk Management: Based on the risk assessment, risk management strategies are developed. This might include updating product labels, issuing safety advisories, or even withdrawing the product from the market.
